Richard A Kerber1, Elizabeth O'Brien. 1. Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112-5550, USA. rich.kerber@hci.utah.edu
Abstract
BACKGROUND: It is well known that genetic variability affects the risk of many cancers, but details of the patterning of inherited cancer risk across different sites and age groups still are not well quantified. METHODS: The authors conducted a nested case-control study of the familial risk of 40 cancers based on a cohort of 662,515 individuals from the Utah Population Database. From 1 to 10 controls selected from the cohort were matched individually on gender, birth year, and birthplace to each cancer case; and familial standardized incidence ratios (FSIR) were calculated for both cases and controls. Conditional logistic regression was used to estimate relative risks and population-attributable risks (PARs) of cancer in relation to FSIR. Relative risks of cancer in first-degree through fifth-degree relatives of cases, compared with controls, were calculated using the proportional hazards methods. All analyses were adjusted for spouse affection status and Latter Day Saints church affiliation. RESULTS: Thirty-five of 40 cancers exhibited positive associations between risk and FSIR, and 21 of those associations were statistically significant. PAR estimates were strikingly high for prostate carcinoma (57%), breast carcinoma (39%), colon carcinoma (32%), lip carcinoma (31%), chronic lymphocytic leukemia (35%), and melanoma (32%). Both the proportion and the number of all cancers attributable to family history peaked at 32% in the group ages 65-84 years and remained high in the group age >/= 85 years. CONCLUSIONS: A substantial portion of cancer risk was attributable to familial factors. The patterns of familial cancer recurrence among distant relatives suggested that simple genetic mechanisms may explain much of the familiality of cancer. (c) 2005 American Cancer Society.
BACKGROUND: It is well known that genetic variability affects the risk of many cancers, but details of the patterning of inherited cancer risk across different sites and age groups still are not well quantified. METHODS: The authors conducted a nested case-control study of the familial risk of 40 cancers based on a cohort of 662,515 individuals from the Utah Population Database. From 1 to 10 controls selected from the cohort were matched individually on gender, birth year, and birthplace to each cancer case; and familial standardized incidence ratios (FSIR) were calculated for both cases and controls. Conditional logistic regression was used to estimate relative risks and population-attributable risks (PARs) of cancer in relation to FSIR. Relative risks of cancer in first-degree through fifth-degree relatives of cases, compared with controls, were calculated using the proportional hazards methods. All analyses were adjusted for spouse affection status and Latter Day Saints church affiliation. RESULTS: Thirty-five of 40 cancers exhibited positive associations between risk and FSIR, and 21 of those associations were statistically significant. PAR estimates were strikingly high for prostate carcinoma (57%), breast carcinoma (39%), colon carcinoma (32%), lip carcinoma (31%), chronic lymphocytic leukemia (35%), and melanoma (32%). Both the proportion and the number of all cancers attributable to family history peaked at 32% in the group ages 65-84 years and remained high in the group age >/= 85 years. CONCLUSIONS: A substantial portion of cancer risk was attributable to familial factors. The patterns of familial cancer recurrence among distant relatives suggested that simple genetic mechanisms may explain much of the familiality of cancer. (c) 2005 American Cancer Society.
Authors: Deborah W Neklason; Thérèse M Tuohy; Jeffery Stevens; Brith Otterud; Lisa Baird; Richard A Kerber; Wade S Samowitz; Scott K Kuwada; Mark F Leppert; Randall W Burt Journal: J Med Genet Date: 2010-06-03 Impact factor: 6.318
Authors: Sampath Prahalad; Andrew S Zeft; Richard Pimentel; Bronte Clifford; Bernadette McNally; Geraldine P Mineau; Lynn B Jorde; John F Bohnsack Journal: Arthritis Rheum Date: 2010-08
Authors: Nikolas H Kazmers; Zhe Yu; Tyler Barker; Tyler Abraham; Robin Romero; Michael J Jurynec Journal: J Hand Surg Am Date: 2019-11-22 Impact factor: 2.230
Authors: Deborah W Neklason; Brett L Thorpe; Angel Ferrandez; Anil Tumbapura; Kenneth Boucher; Gilda Garibotti; Richard A Kerber; Cindy H Solomon; Wade S Samowitz; John C Fang; Geraldine P Mineau; Mark F Leppert; Randall W Burt; Scott K Kuwada Journal: Am J Gastroenterol Date: 2008-07-30 Impact factor: 10.864
Authors: Lynn R Goldin; Magnus Björkholm; Sigurdur Y Kristinsson; Ingemar Turesson; Ola Landgren Journal: Haematologica Date: 2009-03-13 Impact factor: 9.941
Authors: Scott L DuVall; Alison M Fraser; Kerry Rowe; Alun Thomas; Geraldine P Mineau Journal: J Am Med Inform Assoc Date: 2011-09-16 Impact factor: 4.497
Authors: Jazlyn Read; Judith Symmons; Jane M Palmer; Grant W Montgomery; Nicholas G Martin; Nicholas K Hayward Journal: Fam Cancer Date: 2016-10 Impact factor: 2.375
Authors: Heidi A Hanson; Claire L Leiser; Michael J Madsen; John Gardner; Stacey Knight; Melissa Cessna; Carol Sweeney; Jennifer A Doherty; Ken R Smith; Philip S Bernard; Nicola J Camp Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-02-25 Impact factor: 4.254
Authors: Emily L B Lykins; Lili O Graue; Emily H Brechting; Abbey R Roach; Celestine G Gochett; Michael A Andrykowski Journal: Psychooncology Date: 2008-10 Impact factor: 3.894